1. Home
  2. CENT vs ADPT Comparison

CENT vs ADPT Comparison

Compare CENT & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$44.37

Market Cap

2.7B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$25.98

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENT
ADPT
Founded
1955
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
CENT
ADPT
Price
$44.37
$25.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$50.00
$17.78
AVG Volume (30 Days)
94.8K
2.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
57.41
63.89
EPS
2.84
N/A
Revenue
$3,129,100,000.00
$276,976,000.00
Revenue This Year
$1.60
$3.98
Revenue Next Year
$2.04
$22.72
P/E Ratio
$15.48
N/A
Revenue Growth
N/A
54.77
52 Week Low
$28.77
$12.00
52 Week High
$46.97
$26.16

Technical Indicators

Market Signals
Indicator
CENT
ADPT
Relative Strength Index (RSI) 53.24 65.03
Support Level $42.32 $15.08
Resistance Level $45.77 $26.16
Average True Range (ATR) 1.56 1.09
MACD -0.07 -0.05
Stochastic Oscillator 63.75 90.73

Price Performance

Historical Comparison
CENT
ADPT

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: